Paul Russo
Affiliations: | Louisiana State University, Baton Rouge, LA, United States |
Area:
Polymer Chemistry, BiochemistryGoogle:
"Paul Russo"Mean distance: (not calculated yet)
Children
Sign in to add traineeLucille D. Wright | grad student | 2000 | Louisiana State |
Randall C. Cush | grad student | 2003 | Louisiana State |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Blum KA, Huang C, Hakimi AA, et al. (2025) Mini-subcostal incision technique for open radical nephrectomy: A practical alternative for complex renal masses. Urologic Oncology |
Khandwala YS, Reese SW, Ucpinar BA, et al. (2025) Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma. Medrxiv : the Preprint Server For Health Sciences |
Dawidek MT, Calderon LP, Arroyave Villada JS, et al. (2025) Tumors in Solitary Kidneys Are Not All Equal: Outcomes of Partial Nephrectomy in High-Risk Cases. Urology Practice. 101097UPJ00000000000 |
Eismann L, Zucker M, Dawidek MT, et al. (2024) Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma with Synchronous and Metachronous Nodal Disease. Urology Practice. 101097UPJ00000000000 |
Reese SW, Eismann L, White C, et al. (2023) Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma. Urologic Oncology |
Blum KA, Silagy AW, Knezevic A, et al. (2023) Localized Non-Metastatic Sarcomatoid Renal Cell Carcinoma: A 31 Year Externally Verified Study. Bju International |
Hahn AW, Kotecha RR, Viscuse PV, et al. (2023) Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy. European Urology Focus |
Motzer RJ, Russo P, Grünwald V, et al. (2023) Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial. Lancet (London, England) |
Golkaram M, Kuo F, Gupta S, et al. (2022) Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape. Genome Medicine. 14: 143 |
Tourigny DS, Zucker M, Kim M, et al. (2022) Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma. Frontiers in Oncology. 12: 910147 |